Skip to content

Comparison of the efficacy of IV Dexmedetomidine, Pethidine & Tramadol for prevention of perioperative shivering.

Comparison of the efficacy of intravenous Dexmedetomidine, Pethidine & Tramadol for prevention of perioperative shivering in patients undergoing spinal anesthesia for Urological Surgeries. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063501
Enrollment
105
Registered
2024-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: INJ Dexmedetomidine: Drug will be prepared prior in 100 ml NS at dose of 0.5 mcg/kg .After giving Spinal Anesthesia patients will be made to lie in supine position and administered the

Sponsors

IQ CITY MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Sociey of Anaesthesiologists (ASA) Physical status 1 & 2 Patients posted for Urological Surgery Undergoing Spinal Anaesthesia

Exclusion criteria

Exclusion criteria: A. Patient refusal B. Immunocompromised patients C. Local site infection D. Known allergy to local Anaesthesia and study drug E. Cardio-pulmonary, renal or hepatic impairment F. Known history of substance (except tobacco) or alcohol abuse G. An initial axillary temp >37.5°c or H. Blood transfusion during surgery I. Hypo or hyperthyroidism J. Convulsion or psychiatric disorder K. PT (INR) >1.5

Design outcomes

Primary

MeasureTime frame
The present study not only will give us a picture of the efficacy of intravenous Dexmedetomidine, Pethidine, and Tramadol in preventing shivering after spinal anaesthesia in patients undergoing urological surgery.Timepoint: At baseline

Secondary

MeasureTime frame
It will also reflect the intraoperative hemodynamic stability & adverse side effects of the three study drugs. Moreover, it will tell us about patients’ compliance.Timepoint: At baseline

Countries

India

Contacts

Public ContactDEBTANU MAL

IQ CITY MEDICAL COLLEGE & HOSPITAL

sumedh@gmail.com7865985825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026